Collagen Ingredient Reduces Inflammation, Improves Mobility

MURRIETA, Calif.Ongoing clinical trials by Morton Scientific Group of Cambridge in Ontario found KollaGen II-xs (from Certified Nutraceuticals, Inc.) improved joint inflammation and secondary mobility after 30 days.

KollaGen II-xs is a natural blend of mucopolysaccharide compounds and amino acids that are the basic building blocks of joint cartilage. In order for KollaGen II-xs to be effective, important nutrients and capable amino acids are preserved after enzyme digestion occurs in the human body digestive tract. Throughout the clinical study, KollaGen II-xs produced significant clinical therapeutic value for connective tissue disorders and improved the mobility and activity for individuals with joint conditions.

The study included 15 patientseight males and seven femalesbetween the ages of 17 to 81 years. The 15 patients all had confirmed joint damage and cartilage injuries and were diagnosed through imaging and scoping methods with low to high pain scales. Patients supplemented with 1500 mg to 2500 mg KollaGen II-xs and citric juice on an empty stomach.

Results showed that supplementation with KollaGen II-xs produced a significant treatment response

with flexibility increasing at seven days, and a reduction of general pain in 30 days. No adverse events were reported.

They study found KollaGen II-xs may be a viable source for joint management and connective tissue disorders when taken at a dosage of 375 mg to 500 mg, twice a day. The benefits include joint inflammation, secondary mobility and other tertiary effects.

KollaGen II-xs is 100-percent water soluble and can be made into capsules, tablets, beverages and functional foods and cosmetic applications.

Certified Nutraceuticals is a supplier of KollaGen II-xs, a bulk powder that is  manufactured in the United States at a Food and Drug Administration (FDA) and United States Department of Agriculture (USDA)approved facility.